MiR-144-3p inhibits gastric cancer progression and stemness via directly targeting GLI2 involved in hedgehog pathway

Yixun Lu1,2, Benlong Zhang1,2, Baohua Wang1,2

  • 1Medical School of Chinese PLA, Beijing, 100853, China.

Abstract

Insights

MicroRNA-144-3p suppresses gastric cancer (GC) progression by targeting GLI2. This study identifies miR-144-3p as a crucial tumor suppressor in GC, offering potential therapeutic avenues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric cancer (GC) is a leading cause of cancer mortality worldwide, necessitating novel therapeutic targets.
  • MicroRNAs (miRNAs) are critical regulators of tumor initiation and progression.
  • GLI family zinc finger 2 (GLI2) is implicated in various cancers, including GC.

Purpose of the Study:

  • To identify miRNAs targeting GLI2 in gastric cancer.
  • To elucidate the underlying molecular mechanisms of GLI2 regulation by miRNAs in GC.

Main Methods:

  • Analysis of GLI2 and miRNA expression in GC tissues and cell lines.
  • Bioinformatic prediction and dual-luciferase reporter assay for miRNA-target validation.
  • In vitro assays (proliferation, migration, invasion, cell cycle, stemness) and in vivo xenograft models.

Main Results:

  • GLI2 was upregulated in GC, correlating with poor survival.
  • miR-144-3p was downregulated and inversely correlated with GLI2.
  • GLI2 is a direct target of miR-144-3p.
  • miR-144-3p suppressed GC cell proliferation, migration, invasion, and stemness.
  • miR-144-3p inhibited tumor growth in vivo.

Conclusions:

  • miR-144-3p functions as a tumor suppressor in gastric cancer.
  • miR-144-3p inhibits GC progression and stemness by regulating GLI2 expression.